سعر لوبرون ديبوت 22.5 مجم/2مل امبول حقن 2022

Lupron Depot 22.5 mg (3-month depot) by Takeda/Abbott (Egypt): leuprolide acetate, a GnRH agonist given by intramuscular injection for advanced prostate cancer.

• Treatment of advanced prostate cancer.Population: Adult menDailyMed (U.S. National Library of Medicine)

• 22.5 mg 3-month: most common adverse reactions (>10%) were general pain, injection site reaction, hot flashes/sweats, GI disorders, joint disorders, testicular atrophy and urinary disorders.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to GnRH, GnRH agonist analogs or any of the excipients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tumor flare: testosterone rises about 50% above baseline in the first weeks; monitor for bone pain, neuropathy, hematuria, ureteral obstruction and spinal cord compression.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Metabolic syndrome (hyperglycemia, diabetes, hyperlipidemia, fatty liver) and cardiovascular disease (myocardial infarction, sudden cardiac death, stroke) risks; monitor lipids, blood glucose/HbA1c and cardiovascular status.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Androgen deprivation therapy may prolong the QT interval; convulsions and severe cutaneous adverse reactions (SJS/TEN) have been reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• May cause fetal harm (these prostate-cancer strengths are not indicated in females).International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.